Smell tests to distinguish Parkinson’s disease from other neurological disorders: a systematic review and meta-analysis

References

• Engelender S, Isacson O. The threshold theory for Parkinson’s disease. Trends Neurosci. 2017;40:4–14.
   PubMed Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–1601.
   PubMed Web of Science ®Google Scholar
• Sveinbjornsdottir S. The clinical symptoms of Parkinson’s disease. J Neurochem. 2016;139:318–324.
   PubMed Web of Science ®Google Scholar
• Fullard ME, Morley JF, Duda JE. Olfactory dysfunction as an early biomarker in Parkinson’s disease. Neurosci Bull. 2017;33:515–525.
   PubMed Web of Science ®Google Scholar
• Ponsen MM, Stoffers D, Twisk JW, et al. Hyposmia and executive dysfunction as predictors of future Parkinson’s disease: a prospective study. Mov Disord. 2009;24:1060–1065.
   PubMed Web of Science ®Google Scholar
• Doty RL, Shaman P, Kimmelman CP, et al. University of pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope. 1984;94:176–178.
   PubMed Web of Science ®Google Scholar
• Hummel T, Sekinger B, Wolf SR, et al. ‘Sniffin’ sticks’: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses. 1997;22:39–52.
   PubMed Web of Science ®Google Scholar
• Nielsen T, Jensen MB, Stenager E, et al. The use of olfactory testing when diagnosing Parkinson’s disease - a systematic review. Dan Med J. 2018;65:A5481.
   Web of Science ®Google Scholar
• Rey NL, Wesson DW, Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol Dis. 2018;109:226–248.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
   PubMed Web of Science ®Google Scholar
• Shiwa SR, Moseley AM, Maher CG, et al. Language of publication has a small influence on the quality of reports of controlled trials of physiotherapy interventions. J Clin Epidemiol. 2013;66:78–84.
   PubMed Web of Science ®Google Scholar
• Bramer WM. Reference checking for systematic reviews using Endnote. J Med Libr Assoc. 2018;106:542–546.
   PubMed Web of Science ®Google Scholar
• Graph reader web page. Accessed June 21, 2020, http://www.graphreader.com.
   Google Scholar
• Kaizik MA, Garcia AN, Hancock MJ, et al. Measurement properties of quality assessment tools for studies of diagnostic accuracy. Braz J Phys Ther. 2020;24:177–184.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–536.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions version 6.1 ( updated September 2020). Cochrane, Accessed October 10, 2020 from www.training.cochrane.org/handbook.
   Google Scholar
• Driver-Dunckley E, Adler CH, Hentz JG, et al. Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:1260–1262.
   PubMed Web of Science ®Google Scholar
• Wenning GK, Shephard B, Hawkes C, et al. Olfactory function in atypical parkinsonian syndromes. Acta Neurol Scand. 1995;91:247–250.
   PubMed Web of Science ®Google Scholar
• Sengoku R, Matsushima S, Bono K, et al. Olfactory function combined with morphology distinguishes Parkinson’s disease. Parkinsonism Relat Disord. 2015;21:771–777.
   PubMed Web of Science ®Google Scholar
• Chen W, Chen S, Kang WY, et al. Application of odor identification test in Parkinson’s disease in China: a matched case-control study. J Neurol Sci. 2012;316:47–50.
   PubMed Web of Science ®Google Scholar
• Shin HY, Joo EY, Kim ST, et al. Comparison study of olfactory function and substantia nigra hyperechogenicity in idiopathic REM sleep behavior disorder, Parkinson’s disease and normal control. Neurol Sci. 2013;34:935–940.
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Sewell L. Olfactory dysfunction in pure autonomic failure: implications for the pathogenesis of Lewy body diseases. Parkinsonism Relat Disord. 2009;15:516–520.
   PubMed Web of Science ®Google Scholar
• Bovi T, Antonini A, Ottaviani S, et al. The status of olfactory function and the striatal dopaminergic system in drug-induced parkinsonism. J Neurol. 2010;257:1882–1889.
   PubMed Web of Science ®Google Scholar
• Adler CH, Gwinn KA, Newman S. Olfactory function in restless legs syndrome. Mov Disord. 1998;13:563–565.
   PubMed Web of Science ®Google Scholar
• Cochen De Cock V, de Verbizier D, Picot MC, et al. Rhythm disturbances as a potential early marker of Parkinson’s disease in idiopathic REM sleep behavior disorder. Ann Clin Transl Neurol. 2020;7:280–287.
   PubMed Web of Science ®Google Scholar
• Crespo Cuevas AM, Ispierto L, Vilas D, et al. Distinctive olfactory pattern in Parkinson’s disease and non-neurodegenerative causes of hyposmia. Neurodegener Dis. 2018;18:143–149.
   PubMed Web of Science ®Google Scholar
• Djaldetti R, Nageris BI, Lorberboym M, et al. [(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. J Neural Transm (Vienna). 2008;115:469–472.
   PubMed Web of Science ®Google Scholar
• Doty RL, Golbe LI, McKeown DA, et al. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s disease. Neurology. 1993;43:962–965.
   PubMed Web of Science ®Google Scholar
• Doty RL, Singh A, Tetrud J, et al. Lack of major olfactory dysfunction in MPTP-induced parkinsonism. Ann Neurol. 1992;32:97–100.
   PubMed Web of Science ®Google Scholar
• Fernandez-Ruiz J, Diaz R, Hall-Haro C, et al. Olfactory dysfunction in hereditary ataxia and basal ganglia disorders. Neuroreport. 2003;14:1339–1341.
   PubMed Web of Science ®Google Scholar
• Ghielmini E, Poryazova R, Baumann CR, et al. Sleepiness at the time of testing impairs olfactory performance. Eur Neurol. 2013;69:58–64.
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes C, Bentho O, et al. Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism Relat Disord. 2008;14:600–607.
   PubMed Web of Science ®Google Scholar
• Huang SF, Chen K, Wu JJ, et al. Odor identification test in idiopathic REM-behavior disorder and Parkinson’s disease in China. PLoS One. 2016;11:e0160199.
   PubMed Web of Science ®Google Scholar
• Iwanami M, Miyamoto T, Miyamoto M, et al. Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder. Sleep Med. 2010;11:361–365.
   PubMed Web of Science ®Google Scholar
• Katzenschlager R, Costa D, Gerschlager W, et al. I-123 -FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Ann Neurol. 2003;53:489–496.
   PubMed Web of Science ®Google Scholar
• Katzenschlager R, Zijlmans J, Evans A, et al. Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004;75:1749–1752.
   PubMed Web of Science ®Google Scholar
• Kesslak JP, Cotman CW, Chui HC, et al. Olfactory tests as possible probes for detecting and monitoring Alzheimer’s disease. Neurobiol Aging. 1988;9:399–403.
   PubMed Web of Science ®Google Scholar
• Kikuchi A, Baba T, Hasegawa T, et al. Differentiating Parkinson’s disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test. Parkinsonism Relat Disord. 2011;17:698–700.
   PubMed Web of Science ®Google Scholar
• Krismer F, Pinter B, Mueller C, et al. Sniffing the diagnosis: olfactory testing in neurodegenerative parkinsonism. Parkinsonism Relat Disord. 2017;35:36–41.
   PubMed Web of Science ®Google Scholar
• Lee PH, Yeo SH, Kim HJ, et al. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson’s disease and multiple system atrophy. Mov Disord. 2006;21:1975–1977.
   PubMedGoogle Scholar
• Lee PH, Yeo SH, Yong SW, et al. Odour identification test and its relation to cardiac 123I-metaiodobenzylguanidine in patients with drug induced parkinsonism. J Neurol Neurosurg Psychiatry. 2007;78:1250–1252.
   PubMed Web of Science ®Google Scholar
• Lopez Hernandez N, Garcia Escriva A, Shalabi Benavent M. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson’s disease. Neurologia. 2015;30:496–501.
   PubMed Web of Science ®Google Scholar
• Mahlknecht P, Pechlaner R, Boesveldt S, et al. Optimizing odor identification testing as quick and accurate diagnostic tool for Parkinson’s disease. Mov Disord. 2016;31:1408–1413.
   PubMed Web of Science ®Google Scholar
• Miyamoto T, Miyamoto M, Iwanami M, et al. Idiopathic REM sleep behavior disorder: implications for the pathogenesis of lewy body diseases. Parkinsons Dis. 2011;2011:941268.
   Web of Science ®Google Scholar
• Miyamoto T, Miyamoto M, Iwanami M, et al. Odor identification test as an indicator of idiopathic REM sleep behavior disorder. Mov Disord. 2009;24:268–273.
   PubMed Web of Science ®Google Scholar
• Moscovich M, Munhoz RP, Moro A, et al. Olfactory function in SCA10. Cerebellum. 2019;18:85–90.
   PubMed Web of Science ®Google Scholar
• Navarro-Otano J, Gaig C, Muxi A, et al. I-123-MIBG cardiac uptake, smell identification and I-123-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:192–197.
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Hughes G, Church A, et al. Hyposmia in progressive supranuclear palsy. Mov Disord. 2010;25:570–577.
   PubMed Web of Science ®Google Scholar
• Silveira-Moriyama L, Mathias C, Mason L, et al. Hyposmia in pure autonomic failure. Neurology. 2009;72:1677–1681.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Hashimoto M, Yoshioka M, et al. The odor stick identification test for Japanese differentiates Parkinson’s disease from multiple system atrophy and progressive supra nuclear palsy. BMC Neurol. 2011;11:157.
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Suzuki K, Miyamoto T, et al. A card-type odor identification test for Japanese patients with Parkinson’s disease and related disorders. Intern Med. 2017;56:2871–2878.
   PubMed Web of Science ®Google Scholar
• Huttenbrink KB, Hummel T, Berg D, et al. Olfactory dysfunction: common in later life and early warning of neurodegenerative disease. Dtsch Arztebl Int. 2013;110:1–7.
   PubMed Web of Science ®Google Scholar
• Haehner A, Tosch C, Wolz M, et al. Olfactory training in patients with Parkinson’s disease. PLoS One. 2013;8:e61680.
   PubMed Web of Science ®Google Scholar
• Cury RG, Carvalho M, Lasteros FJL, et al. Effects of subthalamic stimulation on olfactory function in Parkinson’s disease. World Neurosurg. 2018;114:e559–64.
   PubMed Web of Science ®Google Scholar
• Saatçi Ö, Yılmaz NH, Zırh A, et al. The therapeutic effect of deep brain stimulation on olfactory functions and clinical scores in Parkinson’s disease. J Clin Neurosci. 2019;68:55–61.
   PubMed Web of Science ®Google Scholar
• Linton Peters M, Ravin P, Novak P, et al. DBS-implanted Parkinson’s disease patients show better olfaction than those treated medically. Neurol Bull. 2010;2:1–6.
   Google Scholar
• Rosenfeldt AB, Dey T, Alberts JL. Aerobic exercise preserves olfaction function in individuals with Parkinson’s disease. Parkinson’s Dis. 2016;2016:1–6.
   PubMed Web of Science ®Google Scholar
• Lemeshow AR, Blum RE, Berlin JA, et al. Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol. 2005;58:867–873.
   PubMed Web of Science ®Google Scholar
• Alekseeva NS, Ponomareva TA. Diagnostics of olfactory disorders in the patients with Parkinson’s disease and polypous sinusitis with the use of the Sniffin’ Sticks test. Vestn Otorinolaringol. 2014;1:37–40.
   Google Scholar
• Imamura K, Matumoto S, Mabuchi N, et al. Relationship between the regional cerebral blood flow and the cognitive function and anosmia in patients with Parkinson disease and Alzheimer disease. Brain Nerve. 2009;61:683–690.
   PubMedGoogle Scholar
• Vodička J, Pellant A, Chrobok V. Screening of olfactory function using odourized markers. Rhinology. 2007;45:164–168.
   PubMed Web of Science ®Google Scholar